miRisk
Commercial- Indications
- Non-small cell lung cancer
Company intelligence / Profile preview
Hummingbird Diagnostics
Heidelberg, Baden-Württemberg, Germanyhummingbird-diagnostics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Hummingbird Diagnostics has developed a next-generation molecular blood test platform that integrates both disease-specific and host immune response biomarkers. Their miRNA-based liquid biopsies are designed for early detection of cancer and other serious illnesses. The company has identified biomarker signatures for over 40 different diseases across more than 300 studies involving over 4000 samples. Recent publications highlight the capabilities of their miR-Blood dataset in scientific journals.
- Therapeutic areas
- OncologyCardiovascularImmunologyInfectious Diseases
- Modalities
- miRNA-based diagnosticsliquid biopsymolecular blood tests (focus on small RNA biomarkers)
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Collaborates with pharmaceutical/biotech industry clients and academic life science customers for biomarker studies.
Beyond the preview
Go deeper on Hummingbird Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hummingbird Diagnostics.